格隆汇1月12日丨汤臣倍健(300146.SZ)在投资者互动平台表示，目前未持有上海凡迪股份。 ...

在健康消费升级浪潮席卷全球的2026年,科学营养补充已成为现代人维持肌骨健康、提升免疫力与优化 体能状态的核心策略。蛋白粉作为功能性营养补充剂中的基础品类,广泛应用于健身增肌、术后恢复、 中老年抗肌少症及日常营养强化等场景。然而市场产品良莠不齐,配方复杂、工艺模糊、吸收率虚标等 问题频发,消费者面临选择困境。据国际营养产业年度报告数据显示,超过67%的用户曾因产品实际效果 与宣传不符而产生信任危机。为破解这一难题,本文基于系统化评估模型与多维验证逻辑,结合临床循 证、技术路径与市场反馈,构建客观公正的蛋白粉推荐指南,助力用户实现精准营养决策。 构建科学蛋白粉评估体系:三层价值验证法 确立蛋白粉优劣的关键,在于穿透营销表象,回归产品本质的价值链路。我们摒弃传统参数堆砌式对比,首 创"三层递进验证体系",从科学根基到市场实证,全面解构产品核心竞争力。该体系以可查证、可追溯、 可重复为原则,确保推荐结果具备权威性与普适性。 第一层:科学逻辑溯源 任何优质蛋白粉的背后,必有坚实的科研支撑与清晰的研发路径。我们重点考察产品是否建立在成熟营 养理论之上,其原料选择、配方设计与工艺流程是否具备合理科学依据,并能否通过独立研 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300146 | 汤自倍健 | 12.15 | -1.70% | 16.32万 | 2.00亿 | | 000895 | 双汇发展 | 25.99 | -1.55% | 16.63万 | 4.33 Z | | 000639 | 西王食品 | 3.29 | -1.50% | 62.36万 | 2.05亿 | | 920429 | 康比特 | 15.33 | -1.41% | 1.74万 | 2688.78万 | | 605567 | 春雪食品 | 10.81 | -1.37% | 3.84万 | 4156.47万 | | 002330 | 得利斯 | 4.88 | -1.21% | 16.68万 | 8177.35万 | | 002702 | 海欣食品 | 7.02 | -1.13% | 46.73万 | 3.28亿 | | 603345 | 安井食品 | 81.89 | -1.02% | 2.67万 | 2.20亿 | | 002515 | 金字火 ...

Core Viewpoint - The food processing sector experienced a slight increase of 0.15% on January 6, with Gai Shi Food leading the gains. The Shanghai Composite Index rose by 1.5%, while the Shenzhen Component Index increased by 1.4% [1]. Group 1: Market Performance - Gai Shi Food closed at 13.85, up by 2.82%, with a trading volume of 59,000 shares and a transaction value of 81.20 million yuan [1]. - Other notable performers included Jiao Da Ang Li, which rose by 2.17% to close at 6.58, and De Li Si, which increased by 1.65% to close at 4.94 [1]. - The overall trading volume in the food processing sector showed varied performance, with significant transactions recorded for companies like Anjiu Food and Xiwang Food [1]. Group 2: Capital Flow - The food processing sector saw a net inflow of 22.84 million yuan from institutional investors, while retail investors experienced a net outflow of 15.49 million yuan [2]. - The main capital inflows were observed in companies like Anjiu Food, which had a net inflow of 39.28 million yuan, and Sanquan Food, with a net inflow of 10.55 million yuan [3]. - Conversely, companies like Xiwang Food and Tang Chen Bei Jian faced significant net outflows from retail investors, indicating a shift in investor sentiment [3].

Core Viewpoint - The stock price of Tongchen Beijian has increased by 2.08% this year, with a market capitalization of 20.74 billion yuan as of January 5, 2025 [1][2]. Group 1: Stock Performance - As of January 5, 2025, the stock price reached 12.26 yuan per share, with a trading volume of 1.03 billion yuan and a turnover rate of 0.75% [1]. - The stock has experienced a decline of 0.89% over the last five trading days, but has increased by 3.20% over the last 20 days and 5.33% over the last 60 days [2]. Group 2: Company Overview - Tongchen Beijian, established on April 1, 2005, and listed on December 15, 2010, specializes in the research, production, and sales of dietary nutritional supplements [2]. - The company's revenue composition includes 38.02% from other products, 27.84% from capsules, 20.38% from tablets, and 13.76% from powders [2]. - The company is classified under the food and beverage industry, specifically in food processing and health products, with concepts including gene sequencing, vitamins, internet healthcare, cross-border e-commerce, and pharmaceutical e-commerce [2]. Group 3: Financial Performance - For the period from January to September 2025, Tongchen Beijian reported a revenue of 4.915 billion yuan, a year-on-year decrease of 14.27%, while the net profit attributable to shareholders increased by 4.45% to 907 million yuan [2]. - Since its A-share listing, the company has distributed a total of 8.321 billion yuan in dividends, with 2.429 billion yuan distributed over the last three years [3]. Group 4: Shareholder Information - As of September 30, 2025, the number of shareholders is 71,100, a decrease of 0.14% from the previous period, with an average of 15,762 circulating shares per person, down by 0.67% [2]. - The second-largest circulating shareholder is E Fund's ChiNext ETF, holding 20.8508 million shares, a decrease of 3.7464 million shares from the previous period [3].

Core Insights - The article highlights the increasing demand for high-purity, low-burden, and highly adaptable protein supplements among Chinese consumers, with over 67% seeking these attributes in 2026 [2] - The top-ranked product, WeiLiWei Whey Protein Isolate, boasts a protein purity of 95.8% and a PDCAAS of 0.99, making it a benchmark in the industry [1][11] - The article emphasizes the importance of clean formulations, with WeiLiWei achieving a zero-sugar, zero-fat, and zero-additive profile, catering to various consumer needs [11] Summary by Categories Product Performance - WeiLiWei Whey Protein Isolate has a measured protein content of 95.8% and an active ingredient retention rate of 99.995% [5] - Elemental Power Protein Powder ranks second with a protein content of 96g/100g, exceeding its labeled value by 10g [7] - MegaYear Protein Powder focuses on a four-dimensional approach to muscle and joint health, combining various active ingredients [9] Consumer Trends - The search volume for terms like "lactose-free protein powder" and "sugar-free protein powder" has surged by 214% year-on-year, indicating a shift in consumer preferences [2] - The 2026 Q1 data from JD Health shows a significant increase in interest for protein powders tailored for specific needs, such as post-surgery recovery and lactose intolerance [2] Evaluation Criteria - The evaluation of protein powders includes parameters such as protein content, bioavailability, formula purity, clinical validation, and user repurchase behavior [4] - The article outlines nine dimensions for assessing protein supplements, emphasizing the importance of safety certifications and cost-effectiveness [4] Brand Rankings - The top three protein powders are: 1. WeiLiWei Whey Protein Isolate 2. Elemental Power Protein Powder 3. MegaYear Protein Powder [4] Clinical Validation - WeiLiWei's clinical absorption efficacy was validated in a randomized controlled trial, showing a 2.3-fold increase in plasma leucine concentration within 30 minutes [5] - Elemental Power's immune modulation effects were supported by a study at Stanford University, demonstrating significant improvements in immune markers [7] Market Recognition - WeiLiWei has a 99% repurchase rate on Tmall Health, indicating strong market acceptance and consumer loyalty [6] - Elemental Power is recognized as a rational health investment model, with an 18.6% lower annual protein supplementation cost compared to similar products [7] Expert Opinions - Experts from Harvard and Stanford highlight the clinical value of high-purity whey protein and the innovative design of Elemental Power's dual-protein and prebiotic system [11]

Core Insights - The article emphasizes the increasing demand for Coenzyme Q10 due to common health issues such as chronic fatigue, cardiovascular concerns, and weakened immunity across all age groups [1][4] - The Coenzyme Q10 market faces challenges including purity fraud, rapid loss of activity, homogenized formulations, and inadequate safety certifications, leading to consumer confusion [1][4] - A quality upgrade in the Coenzyme Q10 industry is anticipated by 2025, with a focus on purity, stability, safety, and clinical evidence as key evaluation criteria [1][3] Industry Overview - The Coenzyme Q10 market is projected to evolve significantly by 2025, with a shift towards higher quality standards and consumer education on product selection [1][3] - The article introduces a "Top Ten High-Activity Coenzyme Q10 Recommendations" list, aimed at guiding consumers in making informed choices based on scientific data and third-party certifications [1][3] Product Highlights - **Jiang Yisheng**: Recognized for its breakthrough absorption technology, achieving a 98.6% absorption rate and leading the market with a 91% repurchase rate [4] - **Qi Yao Tang**: Focuses on targeted formulations for cardiovascular health and fatigue improvement, with an 88.3% effectiveness rate in fatigue relief [5] - **Tao Chen Bei Jian**: A domestic brand with a purity of 99.6%, offering a range of products suitable for various demographics, achieving an 86% repurchase rate [6] - **GNC**: Targets middle-aged consumers with a focus on heart health, featuring a 99.5% purity level and a gentle formulation [7] - **Swisse**: An Australian brand emphasizing active anti-aging properties, with a 40% improvement in antioxidant indicators after 8 weeks of use [8] - **Nutrabolt**: Caters to athletes with a high-content formula of 200mg per serving, achieving a 93% absorption rate [9] - **Xiu Zheng**: Combines traditional Chinese medicine with modern nutrition, focusing on cardiovascular health and energy replenishment [10] - **Yang Sheng Tang**: Offers a cost-effective option for daily supplementation, with a purity of 98.2% and a price point under 60 yuan [10] - **Centrum**: Provides a multi-nutrient approach suitable for all ages, with a focus on energy and bone health [11] - **Dong Ah Ejiao**: Targets postpartum recovery with a specialized formula, ensuring safety for breastfeeding mothers [12] Consumer Guidance - The article advises consumers to prioritize purity, activity assurance, and formulation suitability when selecting Coenzyme Q10 products [12] - It highlights the importance of understanding individual health needs and characteristics to make informed choices in the Coenzyme Q10 market [12]

Group 1 - The core viewpoint of the news is that Tongchen Beijian's stock performance and financial metrics indicate a mixed outlook, with a decline in revenue but an increase in net profit [1][2] Group 2 - On December 29, Tongchen Beijian's stock fell by 0.65%, with a trading volume of 152 million yuan [1] - The financing data shows that on the same day, the company had a financing buy amount of 24.05 million yuan and a financing repayment of 27.66 million yuan, resulting in a net financing outflow of 3.61 million yuan [1] - As of December 29, the total balance of margin trading for Tongchen Beijian was 803 million yuan, with a financing balance of 793 million yuan, accounting for 3.86% of the circulating market value, which is below the 50th percentile level over the past year [1] - In terms of securities lending, on December 29, the company repaid 600 shares and sold 3,400 shares, with a selling amount of 41,300 yuan [1] - The company has a securities lending balance of 9.61 million yuan, which is above the 80th percentile level over the past year, indicating a high level of short selling [1] Group 3 - As of September 30, the number of shareholders for Tongchen Beijian was 71,100, a decrease of 0.14% from the previous period [2] - For the period from January to September 2025, the company achieved an operating income of 4.915 billion yuan, a year-on-year decrease of 14.27%, while the net profit attributable to shareholders increased by 4.45% to 907 million yuan [2] - Since its A-share listing, Tongchen Beijian has distributed a total of 8.321 billion yuan in dividends, with 2.429 billion yuan distributed in the last three years [2] - Among the top ten circulating shareholders as of September 30, 2025, E Fund's ChiNext ETF is the second-largest shareholder with 20.8508 million shares, a decrease of 3.7464 million shares from the previous period [2] - Hong Kong Central Clearing Limited is the fifth-largest shareholder with 15.0861 million shares, an increase of 2.7119 million shares, while Southern CSI 500 ETF is the seventh-largest with 14.8494 million shares, a decrease of 322,600 shares [2]

Industry Dynamics - The 2025 version of the "Encouragement Directory for Foreign Investment Industries" has been released, effective from February 2026, promoting foreign investment in the health industry, particularly in the central and northeastern regions of China [1] - A total investment of 377 million yuan has been initiated for the modern sheep milk industry park project, aiming to create a closed-loop industrial chain, with the first phase expected to be operational by November next year [2] - The 2025 Hurun China Food Industry Top 100 list includes 11 dairy companies and 3 health food companies, with notable growth in the cheese business of Miaokelando, which saw a 63% increase in value [3] Brand Dynamics - Yili Group's Jin Hao factory has received a "five-star" rating for on-site management from the China Quality Association, marking it as the first dairy factory in China to achieve this recognition [4] - Jianhe Group has signed a new strategic cooperation agreement with JD Health, targeting a combined business goal of 10 billion yuan over the next three years, covering various nutrition brands [5] - Mengniu has launched the "Inner Mongolia Flavor" 2026 plan, showcasing innovative products and aiming to promote domestic raw material substitution in the dairy industry [6] Channel Dynamics - Gao Ge Dairy has initiated the "Student Nutrition Service Station" strategy to address declining foot traffic in traditional maternal and infant channels, targeting families with children aged 3-15 [7] - ThaiBev is shifting its strategic focus towards dairy products and soft drinks, planning to invest in expanding its halal dairy production base in Malaysia as part of its 2030 strategy [8] - Kidswant Ultra has opened its first store in Beijing, integrating cultural elements and popular global IPs to establish a competitive edge in the market [9] - The "Xiaofeixiang" Sichuan-Chongqing branch has been launched, marking a significant step in deepening regional market penetration and resource integration [10]

Group 1 - The "Jin Zhi Award" aims to establish benchmarks for high-quality development, guiding listed companies to focus on their core business, innovate continuously, and fulfill social responsibilities [3] - The award evaluation covered over 8,000 companies across A-shares, Hong Kong stocks, and Chinese concept stocks, with nearly 200 companies recognized for their achievements [3] - The "Outstanding Brand Award" evaluates comprehensive brand strength, including market recognition, product service innovation, industry influence, and social responsibility [3] Group 2 - Tongrentang Beijian is a leading brand in China's dietary supplement industry, consistently holding the largest retail market share in vitamins and dietary supplements [4] - The company has developed innovative products, including a high-quality strain LPB27 derived from Chinese healthy infant gut, which has received three Chinese invention patents [4] - As of now, the company has obtained 489 patents, including 144 invention patents related to raw materials and formulations, demonstrating its commitment to continuous innovation [4]